AINEWS
ARPA H, a federal health research agency, just put $33.7M behind AI guided robots for remote stroke care, aiming for the 88% of eligible U.S. patients who never get the clot removing procedure.
Of the roughly 335,000 U.S. patients each year who are eligible for a clot-removing stroke procedure, only about 12% actually receive it. More than half of Americans live more than an hour from a hospital that can perform the procedure. A federal health research agency inside the U.S. Department of Health and Human Services put up to US$33.7 million this week behind a bet that AI-guided robots, operated remotely, can start closing that gap.
ARPA-H, the agency in question, is funding the work through its Autonomous Interventions and Robotics program, led by program director Dr. Ileana Hancu. The award goes to Royal Philips, working with Johns Hopkins University, Boston University, and Dr. J Mocco of Weill Cornell Medicine. ARPA-H is also funding Siemens Healthineers for a parallel stroke-robotics track, per MedTech Dive, making this a multi-vendor program rather than a single-vendor announcement.
The procedure in question is called mechanical thrombectomy. It is a minimally invasive operation in which a catheter is threaded from the groin up into the brain to pull a clot out of a blocked artery. When performed early enough, it can reverse the effects of an ischemic stroke and prevent long-term disability. The clinical model the Philips team is targeting is a hub-and-spoke setup: a neurointerventionalist at a comprehensive stroke center operates the robot over a high-bandwidth link, while the patient is at a smaller hospital that does not currently have the specialists or the equipment on site. Philips announced the project this week. It is built on the company's existing Azurion image-guided therapy platform.
The unmet need goes beyond the U.S. According to the Philips press release, fewer than 3% of eligible patients worldwide with large-vessel occlusion strokes receive mechanical thrombectomy, even though stroke is the world's second leading cause of death. The ARPA-H program page describes the broader push as one that aims to "transform surgical care nationwide", with stroke as one of the first clinical targets.
Endovascular Today frames the award as the start of a research push, not a product launch. The Philips statement calls the project work that will "lay the foundation for a future interventional suite" integrating robotics, AI-enabled automation, and smart devices into a single clinical workflow. The grant funds research, not a near-term clinical rollout; adoption, safety, and outcome data are still years away. Two data points will show whether the bet is working: the first academic site to enroll patients under the Philips award, and whether Siemens' parallel track converges on the same hub-and-spoke model or a different architecture.